Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Aptiv | APTV | Nov 22, 2024 | 54.38 | +1.91 |
Aptorum Group A | APM | Nov 22, 2024 | 0.74 | +0.54 |
Aptose Biosciences | APTO | Nov 22, 2024 | 0.19 | -22.13 |
APx Acquisition I A | APXI | Nov 22, 2024 | 11.87 | 0.00 |
APx Acquisition I Unit | APXIU | Nov 22, 2024 | 11.55 | 0.00 |
Apyx Medical | APYX | Nov 22, 2024 | 1.45 | +1.76 |
Aqua Metals | AQMS | Nov 22, 2024 | 2.16 | +19.34 |
AquaBounty Technologies | AQB | Nov 22, 2024 | 0.94 | -3.60 |
Aquaron Acquisition | AQU | Nov 22, 2024 | 11.10 | 0.00 |
Aquaron Acquisition Units | AQUNU | Nov 22, 2024 | 11.15 | 0.00 |
Aquestive Therapeutics | AQST | Nov 22, 2024 | 4.56 | +1.11 |
Aramark | ARMK | Nov 22, 2024 | 40.86 | +1.09 |
ARB IOT Group | ARBB | Nov 22, 2024 | 0.52 | -5.05 |
Arbe Robotics | ARBE | Nov 22, 2024 | 1.90 | +8.57 |
Arbor Realty Trust | ABR | Nov 22, 2024 | 14.58 | +0.55 |
Arbor Realty Trust D Pref | ABR-D | Nov 22, 2024 | 18.70 | +1.67 |
Arbor Realty Trust E Pref | ABR-E | Nov 22, 2024 | 18.30 | -0.05 |
Arbor Realty Trust F Pref | ABR-F | Nov 22, 2024 | 20.40 | -1.02 |
Arbutus Biopharma | ABUS | Nov 22, 2024 | 3.51 | +1.45 |
ARC Document Solutions | ARC | Nov 22, 2024 | 3.39 | 0.00 |
Arcadia Biosciences | RKDA | Nov 22, 2024 | 2.74 | +5.67 |
Arcadium Lithium | ALTM | Nov 22, 2024 | 5.29 | +0.19 |
ArcBest | ARCB | Nov 22, 2024 | 109.91 | +0.83 |
Arcellx | ACLX | Nov 22, 2024 | 90.44 | +3.69 |
Arcelor Mittal ADR | MT | Nov 22, 2024 | 25.11 | -0.71 |
Arch Capital F Pref | ACGLO | Nov 22, 2024 | 22.90 | +0.57 |
Arch Capital G | ACGLN | Nov 22, 2024 | 19.98 | +0.05 |
Arch Capital Group | ACGL | Nov 22, 2024 | 99.69 | +1.12 |
Arch Resources A | ARCH | Nov 22, 2024 | 173.64 | -0.60 |
Archer Aviation A | ACHR | Nov 22, 2024 | 6.04 | +4.50 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.